Inovio Pharmaceuticals (INO) Interest & Investment Income (2011 - 2026)
Inovio Pharmaceuticals (INO) reported Interest & Investment Income of $363,847 for Q2 2026, down 40.4% from $610,638 a year earlier and down 17.2% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Interest & Investment Income (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Inovio Pharmaceuticals' Interest & Investment Income came in at $1.8 million, down 46.6% year-over-year; for FY2025, it was $2.42 million, down 49.2% from FY2024.
- By year, Interest & Investment Income came in at $4.77 million in FY2024 (-41.4%) and $8.13 million in FY2023.
- The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income since Q4 2018.
- Year over year, Interest & Investment Income has now declined in each of the last eight quarters, with an average decline of 47.4% over the last eight quarters.
- The year-over-year decline in Interest & Investment Income has ranged between 40.4% (Q2 2026) and 53.3% (Q2 2025) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $439,593 (Q1 2026), $449,337 (Q4 2025) and $552,108 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Inovio Pharmaceuticals | 94.68 Mn | 94.68 Mn | - | 363,847.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 363,847.00 |
| Mar 31, 2026 | 439,593.00 |
| Dec 31, 2025 | 449,337.00 |
| Sep 30, 2025 | 552,108.00 |
| Jun 30, 2025 | 610,638.00 |
| Mar 31, 2025 | 808,077.00 |
| Dec 31, 2024 | 852,587.00 |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 1.82 Mn |
| Sep 30, 2023 | 1.94 Mn |
| Dec 31, 2018 | -169,300.00 |
| Sep 30, 2018 | 380,987.00 |
| Jun 30, 2018 | 396,681.00 |
| Mar 31, 2018 | 312,523.00 |
| Dec 31, 2017 | 509,266.00 |
| Sep 30, 2017 | 463,346.00 |
| Jun 30, 2017 | 300,021.00 |
| Mar 31, 2017 | 340,341.00 |
API Access
Inovio Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();